Jerzy Gumulka

Insider Reports History

Location: Houston, TX
Signature: /s/ Christopher Downs, Attorney-in-Fact
All insider transactions: Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Jerzy Gumulka:

Form 4 holding Director

CNS Pharmaceuticals, Inc.

Security class: Option to purchase common stock
Shares / value: 1,517
Estimated value
Report date: 17 Nov 2025
Price
Ownership: Direct
Underlying class: Common Stock
Underlying amount

Insider Reports Filed by Jerzy Gumulka

4 CNSP

CNS Pharmaceuticals, Inc.

Report period: 17 Nov 2025
Transactions: 1
Transaction value: $0
Filing time: 19 Nov 2025, 17:00
Role: Director
Next action: Open filing details

4 CNSP

CNS Pharmaceuticals, Inc.

Report period: 08 Apr 2024
Transactions: 2
Transaction value: $0
Filing time: 10 Apr 2024, 21:52
Role: Director
Next action: Open filing details

4 CNSP

CNS Pharmaceuticals, Inc.

Report period: 01 Feb 2024
Transactions: 3
Transaction value: +$10,000
Filing time: 06 Feb 2024, 10:28
Role: Director
Next action: Open filing details

4/A CNSP

CNS Pharmaceuticals, Inc.

Report period: 21 Sep 2023
Transactions: 1
Transaction value: $0
Filing time: 12 Oct 2023, 18:01
Role: Director
Next action: Open filing details

4 CNSP

CNS Pharmaceuticals, Inc.

Report period: 19 Apr 2023
Transactions: 1
Transaction value: +$4,250
Filing time: 21 Apr 2023, 07:58
Role: Director
Next action: Open filing details

4 CNSP

CNS Pharmaceuticals, Inc.

Report period: 10 Apr 2023
Transactions: 1
Transaction value: +$5,308
Filing time: 17 Apr 2023, 08:17
Role: Director
Next action: Open filing details

4 CNSP

CNS Pharmaceuticals, Inc.

Report period: 15 Jul 2021
Transactions: 1
Transaction value: $0
Filing time: 16 Jul 2021, 17:00
Role: Director
Next action: Open filing details

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .